Medication info
Dapagreen Tablet 5 mg (Dapagliflozin Propanediol Hydrate)

Dapagreen Tablet 5 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
Yellow, bilaterally convex, round, film-coated tablet
Packaging
Box - 28 tablets/box [14 tablets/PTP (Alu-Alu) x 2], Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Approval status
Active

MFDS item code 202300421 · Approved 2023.01.31 · Insurance code 650304450

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus; reduces the risk of progression of chronic kidney disease and death
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this drug is 5mg once daily or 10mg once daily. Chronic kidney disease The recommended dose of this drug is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this drug is not recommended in patients with chronic kidney disease. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus; reduces the risk of progression of chronic kidney disease and death

  • Type 2 diabetes
  • blood sugar control disorder
  • cardiovascular disease
  • cardiovascular risk factors
  • chronic kidney disease
  • estimated glomerular filtration rate reduction
  • end-stage kidney disease
  • death from cardiovascular disease
  • risk of renal-related death
View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It can be administered either alone or in combination as an adjunct to dietary and exercise therapy. It is also applicable to patients with type 2 diabetes who are at risk of cardiovascular disease. Additionally, in patients with chronic kidney disease, it slows the progression of reduced kidney function and decreases the risk of cardiovascular and kidney-related mortality. In this case, it is used in conjunction with other chronic kidney disease treatments. In summary, this medication helps improve the main symptoms and complications of patients with type 2 diabetes and chronic kidney disease.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this drug is 5mg once daily or 10mg once daily. Chronic kidney disease The recommended dose of this drug is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this drug is not recommended in patients with chronic kidney disease. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients who have had allergic reactions to its active ingredients or excipients. Additionally, it should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. This medication contains anhydrous lactose, so patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take it. Patients undergoing dialysis should also avoid using this medication. Patients with reduced fluid volume or kidney function issues should use this medication with caution, and blood pressure and kidney function must be carefully monitored before and after administration. In particular, in patients with moderate or more severe kidney impairment, the blood sugar control effect of this medication may be reduced, so consultation with a specialist is advised. During the use of this medication, genital infections or urinary tract infections may occur, so immediate treatment is necessary if symptoms of infection arise. There may be symptoms of hypoglycemia, so when used with insulin or sulfonylureas, dosage adjustment may be required. This medication can cause dehydration or low blood pressure, so if reduced fluid volume is suspected, temporary cessation of use may be necessary. Severe metabolic abnormalities, such as diabetic ketoacidosis, can occur, so if symptoms like vomiting, abdominal pain, or shortness of breath occur, healthcare professionals should be notified immediately. Patients with severely impaired liver function, pregnant women, and breastfeeding women should avoid taking this medication. Elderly patients are at a higher risk of kidney impairment and reduced fluid volume, so extra caution is needed. Also, the safety and efficacy of this medication have not been established in children, so it should not be used in pediatric patients. In case of overdose, seek immediate medical attention, and while this medication does not significantly affect driving or operating machinery, caution is advised considering the risk of hypoglycemia. Finally, this medication should be stored in its original packaging and kept out of reach of children.

Side effects

Vulvitis, balanitis and related genital infections, urinary tract infection, fungal infection, perineal necrosis, hypoglycemia, fluid volume depletion, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, vulvar pruritus, genital pruritus, increased hematocrit, reduced creatinine clearance in the early stages of treatment, dyslipidemia, increased blood creatinine in the early stages of treatment, increased blood urea, weight loss, rash, angioedema, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, gastrointestinal disorders, hyperglycemia, sensory abnormalities, cerebral infarction, nerve compression, weakness, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, chronic gastritis, diverticulosis, pneumoperitoneum, frequent bowel movement, gastroenteritis, colon polyp, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gingival disorders, gingival pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic gastritis, gastrointestinal disorders, abdominal discomfort, abdominal pain, gastroesophageal reflux disease, esophagitis, lower abdominal pain, upper abdominal pain, enteritis, gastric ulcer, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, urolithiasis, abnormal urine, urgency, increased blood lactate, lymphopenia, weight gain, vitamin D deficiency, increased appetite, taste disorders, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, bronchitis, herpes zoster, sinusitis, tonsillitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, peri-coronal inflammation, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like syndrome, chest pain, fatigue, pain, edema, foreign body sensation, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, pruritus, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Yellow, bilaterally convex, round, film-coated tablet

Package unit

Box - 28 tablets/box [14 tablets/PTP (Alu-Alu) x 2], Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.